Form 4: Aadi Bioscience Executive Chairman Neil Desai Sells Shares
SEC Form 4
Neil Desai, Executive Chairman of Aadi Bioscience, sold shares of the company's common stock on July 1st and 2nd, 2024, according to a Form 4 filing with the SEC.
Summary
- Neil Desai, the Executive Chairman of Aadi Bioscience, sold shares of the company's common stock on July 1st and 2nd, 2024.
- On July 1st, Desai sold 31,348 shares at a weighted average price of $1.4548.
- On July 2nd, Desai sold 8,652 shares at a weighted average price of $1.3421.
- The sales were executed under a Rule 10b5-1 trading plan adopted on September 20, 2021, and replaced on December 1, 2022.
- Following these transactions, Desai directly owns no shares, but indirectly owns 1,251,543 shares through the Anishka Family Trust, where he serves as trustee, and 639,698 shares through the Anishka Irrevocable 2016 Trust.
Sentiment
Score: 5
Explanation: Neutral. This is a standard Form 4 filing indicating share sales by an executive. The sales were conducted under a pre-arranged trading plan, suggesting they may not be directly indicative of the executive's current outlook on the company.
Industry Context
This filing is a routine disclosure of insider trading activity. It's important to monitor such filings to understand the sentiment of company executives regarding the company's prospects.
Stakeholder Impact
- Shareholders may interpret the share sales as a negative signal, although the pre-arranged trading plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2021-09-20 | Original adoption date of Rule 10b5-1 trading plan. |
| 2022-12-01 | Replacement date of Rule 10b5-1 trading plan. |
| 2024-07-01 | Date of first reported share sale (31,348 shares). |
| 2024-07-02 | Date of second reported share sale (8,652 shares). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.